RedHill Biopharma Announces Allowance of a Patent in Japan Supporting RHB104 for Multiple Sclerosis

RedHill has received from the Japan Patent Office a Notice of Allowance for a new patent covering RHB104 for multiple sclerosis MS expected to be valid until 2032 once grantedRedHills robust RHB104 patent portfolio covering its oral antibiotic combination ...